The Current State of Perioperative Chemotherapy in Resectable Colorectal Liver Metastases: A Narrative Review

ABSTRACT Perioperative chemotherapy has emerged as a critical component in managing resectable colorectal liver metastases (CRLM), aiming to improve long‐term survival, although data supporting its use remains controversial. This narrative review explores the current state of perioperative chemotherapy in patients with resectable CRLM, focusing on its role in different oncological risk categories. The review highlights ongoing controversies, such as optimal patient selection and the role of post‐ versus preoperative treatment in specific scenarios.